SHANNA HILLERICH: Open Payments
NPI 1740477223 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 61 payments from 17 companies in 2025. Trend: 2023 $1,014 · 2024 $1,141 · 2025 $1,544
Food & beverage: $1,544
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $284 |
| Fresenius USA Marketing, Inc. | 10 | $219 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $148 |
| Amgen Inc. | 9 | $146 |
| NxStage Medical, Inc. | 2 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $111 |
| Travere Therapeutics, Inc. | 4 | $103 |
| Ardelyx, Inc. | 4 | $71 |
| Mallinckrodt Hospital Products Inc. | 2 | $59 |
| Calliditas Therapeutics US Inc. | 3 | $54 |
Products named: VELPHORO, FARXIGA, JARDIANCE, TAVNEOS, NXSTAGE SYSTEM ONE, Kerendia, IBSRELA, TERLIVAZ.
Industry payments across KY — which companies pay providers there.
